Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 26,051 | 32,439 | 24,353 | 28,966 | 15,128 |
| Operating Income | -26,051 | -32,439 | -24,353 | -28,966 | -15,128 |
| Other Income | 22 | 15 | 23 | 33 | 38 |
| Pre-tax Income | -26,029 | -32,424 | -24,330 | -28,933 | -15,090 |
| Net Income Continuous | -26,029 | -32,424 | -24,330 | -28,933 | -15,090 |
| Net Income | $-26,029 | $-32,424 | $-24,330 | $-28,933 | $-15,090 |
| EPS Basic Total Ops | -0.74 | -0.93 | -0.70 | -0.83 | -0.43 |
| EPS Basic Continuous Ops | -0.74 | -0.93 | -0.70 | -0.83 | -0.43 |
| EPS Diluted Total Ops | -0.74 | -0.93 | -0.70 | -0.83 | -0.43 |
| EPS Diluted Continuous Ops | -0.74 | -0.93 | -0.70 | -0.83 | -0.43 |
| EBITDA(a) | $-25,905 | $-32,067 | $-23,942 | $-28,774 | $-14,996 |